Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Segrén

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Cancer|May 10, 1991
Tumour-growth suppression in nude mice by a murine monoclonal antibody: factors hampering successful therapyC Johansson, S Segrén, L Lindholm
Scandinavian Journal of Immunology|October 1, 1986
Evidence for the existence of W3/13+ monocytes in the ratG Hedlund, S Segrén, B Jansson, et al.
Human Gene Therapy|July 13, 2000
Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cellsX Fan, A Brun, S Segrén, et al.
The EMBO Journal|July 3, 1995
Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin AL Abrahmsén, M Dohlsten, S Segrén, et al.
Journal of Immunological Methods|October 23, 1986
Magnetic carbohydrate nanoparticles for affinity cell separationU Schröder, S Segrén, C Gemmefors, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1996
Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificityD W Newton, M Dohlsten, C Olsson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1991
A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cellsG Hedlund, M Dohlsten, T Herrmann, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Cancer|May 10, 1991
Tumour-growth suppression in nude mice by a murine monoclonal antibody: factors hampering successful therapyC Johansson, S Segrén, L Lindholm
Scandinavian Journal of Immunology|October 1, 1986
Evidence for the existence of W3/13+ monocytes in the ratG Hedlund, S Segrén, B Jansson, et al.
Human Gene Therapy|July 13, 2000
Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cellsX Fan, A Brun, S Segrén, et al.
The EMBO Journal|July 3, 1995
Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin AL Abrahmsén, M Dohlsten, S Segrén, et al.
Journal of Immunological Methods|October 23, 1986
Magnetic carbohydrate nanoparticles for affinity cell separationU Schröder, S Segrén, C Gemmefors, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1996
Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificityD W Newton, M Dohlsten, C Olsson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1991
A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cellsG Hedlund, M Dohlsten, T Herrmann, et al.
Pageof 1